Inspections, Compliance, Enforcement, and Criminal Investigations
Azteca Linda Corp - Close Out Letter 4/22/11
| Public Health Service Food and Drug Administration |
New York District |
April 22, 2011
Avelardo Carrera, President
Azteca Linda Corp.
d.b.a. Queso El Azteca
898 Flushing Avenue
Brooklyn, New York 11206
Dear Mr. Canera:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NYK-2011-12 dated January 7, 2011. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Dean Rugnetta
Compliance Officer
New York District





Department of Health and Human Services

